Fullife Healthcare receives $22 million funding from Morgan Stanley Private Equity Asia
The investment will be instrumental in accelerating the growth of Fast&Up and Chicnutrix brands
Fullife Healthcare raised its Series C funding of $22 million by Morgan Stanley Private Equity Asia (MSPEA). Fullife Healthcare is the pioneer manufacturer in effervescent technology for healthcare and nutraceutical products. The company owns two brands Fast&Up and Chicnutrix, Fullife Healthcare notified yesterday via a statement.
The statement further said that Fullife Healthcare is one of the first Indian companies to take branded business outside India in the field of wellness and active nutrition.
Commenting on the capital raise, Varun Khanna, CEO, Fullife Healthcare, said, “……Our focus has always been to bring forth high-quality nutrition to India, making sure that Indians get the best-in-class supplements to keep them active and feeling good. Indians are now more aware and actively searching for products that are genuine, high quality and align with the daily needs to be healthy, active and look good. We are building these brands at an international level even in several regulated markets as a first for Indian OTC brands.”
According to the statement, this round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally. Both of these home-grown brands have been entering into new categories and leading the pack when it comes to providing nutrition solutions for a healthy and active lifestyle.